Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
20
Number of overlapping holdings
37.7%
% of PINK's 56 holdings also in FMED
34.5%
% of FMED's 65 holdings also in PINK
Overlap by Weight
Sector Drift (PINK minus FMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PINK |
Weight in FMED |
Overlap | |
|---|---|---|---|---|
 |
UNITEDHEALTH GROUP INC | 5.4% | 4.7% | 4.7% |
|
BOSTON SCIENTIFIC CORP | 4.2% | 5.6% | 4.2% |
|
INTUITIVE SURGICAL INC | 4.8% | 3.8% | 3.8% |
|
REGENERON PHARMACEUTICALS | 4.8% | 3.8% | 3.8% |
|
ELI LILLY & CO | 6.5% | 2.3% | 2.3% |
Position Highlights (Non-Overlapping Exposures)
PINK Overweight Relative to FMED
|
SAREPTA THERAPEUTICS INC | 9.2% |
|
PURECYCLE TECHNOLOGIES INC | 5.8% |
 |
SANOFI-AVENTIS-ADR | 5.0% |
|
ELI LILLY & CO | 4.1% |
 |
NOVO-NORDISK A/S-SPONS ADR | 3.5% |
|
GILEAD SCIENCES INC | 3.1% |
|
3M CO | 3.1% |
|
JOHNSON & JOHNSON | 2.7% |
|
NEUROCRINE BIOSCIENCES INC | 2.3% |
|
MERCK & CO. INC. | 2.2% |
PINK Underweight Relative to FMED
|
ALNYLAM PHARMACEUTICALS INC | -4.4% |
|
DANAHER CORP | -3.7% |
|
INSULET CORP | -3.4% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.0% |
 |
ARGENX SE ADR | -2.3% |
|
UCB SA | -2.3% |
|
STRYKER CORP | -2.2% |
|
PENUMBRA, INC. | -2.1% |
|
EXACT SCIENCES CORP | -2.0% |
|
LIFESTANCE HEALTH GROUP, INC. | -2.0% |